TipRanks
Grace Therapeutics (DE:L8S)
FRANKFURT:L8S
Germany Market
L8S
Grace Therapeutics
RESEARCH TOOLSreports

Grace Therapeutics (L8S) Income Statement

0 Followers

Grace Therapeutics Income Statement

Last quarter (Q1 2027), Grace Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Grace Therapeutics's net income was C$-15.79M. See Grace Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 11.08M$ 23.75M$ 17.44M$ 70.54M$ 19.48M
Depreciation and Amortization
$ 7.00K$ 9.97K$ 54.28K$ 167.71K$ 0.00
EBITDA
$ -11.07M$ -23.74M$ -15.37M$ -24.51M$ -19.17M
Operating Income
$ -11.08M$ -23.75M$ -17.44M$ -70.54M$ -19.48M
Other Income/Expenses
$ 1.58M$ 5.57M$ -2.49M$ 248.87K$ 6.40M
Pretax Income
$ -9.49M$ -18.18M$ -19.93M$ -70.29M$ -13.08M
Net Income
$ -7.79M$ -13.63M$ -17.44M$ -57.39M$ -12.27M
Per Share Metrics
Basic EPS
$ -0.47$ -1.13$ -1.83$ -7.72$ -2.02
Diluted EPS
$ -0.47$ -1.13$ -1.83$ -7.72$ -2.02
Weighted Average Shares Outstanding
 16.51M 12.09M 9.53M 7.44M 6.14M
Weighted Average Shares Outstanding (Diluted)
 16.51M 12.09M 9.53M 7.44M 6.14M

Grace Therapeutics Earnings and Revenue History